Opioid manufacturing quotas could limit access in 2020

Veterinarians could face shortages when treating patients Veterinary access to five Schedule II opioids could be reduced next year under a proposal by the U.S. Drug Enforcement Administration (DEA) to limit the amount of these drugs that can be manufactured … read more >